Recognizing the significant and often overlooked behavioral health needs experienced by individuals and families affected by rare diseases, and for other purposes.
Impact on your practice
This recognition resolution could lay groundwork for future insurance coverage expansions for behavioral health in rare disease populations, but currently has no direct practice impact. Therapists treating rare disease patients should monitor for follow-up policy.
Key facts
Recognizes behavioral health needs of rare disease patients and families
Early-stage resolution referred to House Energy and Commerce
May lead to future policy on rare disease mental health coverage
Could influence insurance coverage guidelines for specialized populations
No immediate regulatory or payment impact
Policy changes drive denial patterns
Therapy Companion tracks both: the policy shifts on this page and the denial patterns hitting your claims.
Related policy changes
A New Federal Interpretation Challenges the ‘Gold Standard’ of SMI Care
This DOJ memo could fundamentally reshape where and how community-based mental health services are funded and delivered. Therapists working in community-integrated programs or value-based models should monitor this closely, as it may affect referral patterns, funding models, and scope of practice in community settings.
Behavioral Health Billing Fraud, Kickbacks Totalled $208M in Massive DOJ Fraud Bust
This enforcement action underscores heightened scrutiny of behavioral health billing practices, particularly around rapidly-growing modalities like TMS. Therapists and practices should audit billing accuracy and documentation, especially in high-fraud areas. Overly aggressive billing practices or inadequate supervision documentation now carry real federal prosecution risk.
Advancing the Future of Behavioral Health Data Exchange
Better behavioral health data exchange is a regulatory and operational priority that will likely drive new EHR interoperability requirements and documentation standards for therapists. Understanding this movement helps practices anticipate compliance changes.
STAT+: Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policy
Federal marijuana rescheduling will complicate assessment, treatment planning, and documentation for therapists, particularly around substance use evaluation and dual diagnoses. Therapists in legal marijuana states will need updated clinical guidelines and liability coverage clarity.